Brigham discusses the rigorous standards compounding pharmacies must adhere to, often surpassing those of big pharmaceutical companies. He highlights the ongoing issues with drug shortages in the U.S. and the FDA's lack of transparency regarding these critical medications. The conversation reveals the tension between independent pharmacies and larger pharmaceutical entities, emphasizing the need for quality and accessibility in healthcare.
